yolk sac tumor
yolk sac tumor
Explore linked clinical trials. Standard reference: MONDO:000574411 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, embryonal carcinoma, immature ovarian teratoma, malignant germ cell tumor, mesonephric neoplasm, neoplasm, teratoma, yolk sac tumor | Recruiting | Phase 3 | 2026-08-25 | NCT03067181 | |
| Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, benign urinary system neoplasm, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, liposarcoma, liver cancer, liver disorder, mesonephric neoplasm, mixed neoplasm, myomatous neoplasm, neoplasm, rhabdoid tumor, rhabdomyosarcoma, sarcoma, urinary system disorder, yolk sac tumor | Recruiting | Phase 1 | 2026-08-06 | NCT04715191 | |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | Female Urogenital Diseases and Pregnancy Complications, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, Pregnancy Complications, Neoplastic, Urogenital Diseases, adenocarcinoma, carcinoma, choriocarcinoma, epithelial neoplasm, extragonadal seminoma, germinoma, malignant germ cell tumor, mesonephric neoplasm, mixed germ cell tumor, neoplasm, nongerminomatous germ cell tumor, pregnancy disorder, seminoma, teratoma, trophoblastic neoplasm, yolk sac tumor | Active, not recruiting | Phase 3 | 2026-06-16 | NCT02375204 | |
| Agnostic Therapy in Rare Solid Tumors | Adnexal Diseases, Biliary Tract Neoplasms, Carcinoma, Ovarian Epithelial, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, MIT family translocation renal cell carcinoma, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Parathyroid Neoplasms, Pregnancy Complications, Neoplastic, Sertoli-Leydig cell tumor, Sex Cord-Gonadal Stromal Tumors, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adenoid cystic carcinoma, adenoma, adrenal gland cancer, adrenal gland disorder, angiosarcoma, anus disorder, anus neoplasm, apocrine adenocarcinoma, benign urinary system neoplasm, biliary tract disorder, bladder urachal adenocarcinoma, bladder urachal carcinoma, breast secretory carcinoma, capillary hemangioma, carcinoma, carcinosarcoma, cholangiocarcinoma, colorectal neoplasm, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, fibrolamellar hepatocellular carcinoma, fibrosarcoma, gallbladder disorder, gallbladder neoplasm, gonadal disorder, gonadal tissue neoplasm, granulosa cell tumor, hemangioblastoma, hemangioma, hepatoblastoma, intestinal disorder, leiomyosarcoma, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, mesonephric neoplasm, mesothelial neoplasm, mesothelioma, metaplastic breast carcinoma, mixed neoplasm, myomatous neoplasm, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroblastoma, neuroendocrine neoplasm, neuroepithelial neoplasm, neurofibroma, neurofibrosarcoma, neuromuscular disease, osteosarcoma, ovarian cancer, ovarian disorder, parathyroid gland carcinoma, parathyroid gland disorder, penile disorder, penile neoplasm, peripheral nervous system disorder, peripheral nervous system neoplasm, pregnancy disorder, primitive neuroectodermal tumor, rectal disorder, rectal neoplasm, sarcoma, testicular cancer, testicular disorder, thyroid gland disorder, thyroid tumor, trophoblastic neoplasm, urethra neoplasm, urethral disorder, urinary system disorder, vaginal cancer, vaginal disorder, vascular cancer, viral infectious disease, vulva cancer, vulvar disease, yolk sac tumor | Recruiting | Phase 2 | 2026-04-15 | NCT06638931 | |
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, hepatocellular carcinoma, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, liposarcoma, liver disorder, mesonephric neoplasm, mixed neoplasm, myomatous neoplasm, neoplasm, rhabdoid tumor, rhabdomyosarcoma, sarcoma, undifferentiated embryonal sarcoma of the liver, urinary system disorder, yolk sac tumor | Active, not recruiting | Phase 1 | 2026-03-06 | NCT05103631 | |
| Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, hepatoblastoma, hepatocellular carcinoma, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, liposarcoma, liver disorder, mesonephric neoplasm, mixed neoplasm, myomatous neoplasm, neoplasm, rhabdoid tumor, rhabdomyosarcoma, sarcoma, urinary system disorder, yolk sac tumor | Recruiting | Phase 1 | 2026-02-17 | NCT07148050 | |
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, benign urinary system neoplasm, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, liposarcoma, liver cancer, liver disorder, mesonephric neoplasm, mixed neoplasm, myomatous neoplasm, neoplasm, rhabdoid tumor, rhabdomyosarcoma, sarcoma, urinary system disorder, yolk sac tumor | Active, not recruiting | Phase 1 | 2026-01-21 | NCT04377932 | |
| Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liposarcoma, liver disorder, mesonephric neoplasm, myomatous neoplasm, neoplasm, rhabdomyosarcoma, sarcoma, yolk sac tumor | Not yet recruiting | Phase 1 | 2025-11-04 | NCT07224568 | |
| Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, hepatoblastoma, hepatocellular carcinoma, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, liposarcoma, liver disorder, mesonephric neoplasm, mixed neoplasm, myomatous neoplasm, neoplasm, rhabdoid tumor, rhabdomyosarcoma, sarcoma, urinary system disorder, yolk sac tumor | Recruiting | Phase 1 | 2025-11-03 | NCT06198296 | |
| Molecular Epidemiology of Pediatric Germ Cell Tumors | Female Urogenital Diseases and Pregnancy Complications, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Pregnancy Complications, Neoplastic, Urogenital Diseases, adenocarcinoma, carcinoma, childhood germ cell tumor, choriocarcinoma, embryonal carcinoma, epithelial neoplasm, germinoma, mesonephric neoplasm, mixed germ cell tumor, neoplasm, pregnancy disorder, teratoma, trophoblastic neoplasm, yolk sac tumor | Recruiting | Not stated | 2025-10-24 | NCT05564026 | |
| High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors | Female Urogenital Diseases and Pregnancy Complications, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, Pregnancy Complications, Neoplastic, Urogenital Diseases, adenocarcinoma, carcinoma, choriocarcinoma, epithelial neoplasm, germinoma, mesonephric neoplasm, neoplasm, pregnancy disorder, seminoma, teratoma, trophoblastic neoplasm, yolk sac tumor | Recruiting | Phase 2 | 2025-08-03 | NCT06418789 |